Redundancy negotiation concept
Adobe
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Toll road player Transurban Group (ASX:TCL) has issued a sombre notice to the market on Thursday, depending on which side you’re on, revealing the company plans to cut 300 jobs.

That’s the real admission made to the market; perhaps because it’s already confessions season, what could have been a negative response might get lost along other big news.

(To be fair, job cuts are usually a good thing for share prices, unless mass redundancies pop up out of nowhere in apparent contradiction of fundamentals.)

The news ultimately culminates a ‘workforce review’ kicked off back in 2024.

“Transurban aims to be a leader in helping people move more easily and safely around major cities,” TCL CEO Michelle Jablko.

“To do this, we must be a more agile and efficient organisation and re-allocate our capital and resources in ways that best serve our stakeholders.” The thoughts of commuters paying the tolls weren’t mentioned. (Nor employees getting the chop.)

All in all, the company anticipates having more than $50M in cash lying around after the job cuts, compared at least to what it imagines it otherwise would’ve paid in wages.

The news is unlikely to stir too many waters: FY25 guidance is unchanged.

TCL last traded at $14.31/sh.

Join the discussion: See what HotCopper users are saying about TCL and be part of the conversations that move the markets.

TCL by the numbers
More From The Market Online
Market concept

(Last) Market Close (of 2025): October back again as DRO, EOS & 4DX pop; otherwise mid day

If you wanted to feel like you were re-living the festivity season for the XJO that was October, look no further than today’s

EV Resources on ‘accelerated pathway’ to Los Lirios restart after strong antimony recovery tests

EV Resources is inching closer to a Los Lirios restart after strong metallurgical results set up…
Magneto scan concept

MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY

Compumedics, a biotech company developing its Orion Lifespan MEG product, could just be the next big…

Coles, Woolies left furious over gov’t checks designed to limit ‘excessive pricing on groceries’

Coles and Woolworths have come out swinging against the government's plan to impose stricter rules to…